
With patients buying gray-market peptides, HHS’s draft policy aims to reunite prescribers, patients, and pharmacists around these emerging products.
Young kidney transplant patients are more likely not to comply with their anti-rejection drugs than adult or pediatric patients, according to a new GAO report.
A new Government Accountability Office






